MNT (PMP) Overview
MNT (PMP) is a compounded multi-component solution formulated for laboratory and analytical research applications. The formulation combines trimethylglycine (TMG), CDP-choline (citicoline), and several amino acids commonly studied in nitric oxide signaling, methylation balance, neurotransmitter precursor pathways, and metabolic research models.
The solution is prepared in sterile water with benzyl alcohol as a preservative and is intended exclusively for controlled research environments.
MNT (PMP) is not approved for human or veterinary use and is supplied strictly for laboratory and analytical research purposes.
Mechanism of Action
MNT (PMP) is evaluated as a combined formulation rather than a single active compound. Each component contributes to research-relevant biochemical pathways:
-
Trimethylglycine (TMG, Betaine): Studied as a methyl donor involved in homocysteine and one-carbon metabolism.
-
CDP-Choline (Citicoline): Investigated for phospholipid synthesis, choline availability, and cellular membrane signaling pathways.
-
Arginine: Studied as a precursor to nitric oxide (NO) via nitric oxide synthase pathways.
-
N-Acetyl-L-Tyrosine (NALT): Examined as a tyrosine source in catecholamine-related research models.
-
Norvaline: Investigated as an arginase pathway modulator in nitric oxide research contexts.
-
Lysine: Studied for protein synthesis and amino acid transport research.
-
Citrulline: Examined for arginine recycling and nitric oxide pathway support.
The combined formulation is explored in research models involving nitric oxide signaling, methylation dynamics, amino acid synergy, and metabolic regulation.
Chemical Structure
Primary Identifying Compound:
CDP-Choline (Citicoline)
Chemical Name:
Cytidine 5′-diphosphocholine
Synonyms:
CDP-Choline, Citicoline
Molecular Formula:
C₁₄H₂₆N₄O₁₁P₂
Molecular Weight:
488.32 g/mol
CAS Number:
33818-15-4
Structural Description:
CDP-Choline is a nucleotide intermediate composed of cytidine linked to choline via a diphosphate bridge. This structure underlies its role in phosphatidylcholine biosynthesis and membrane-related metabolic research. Structural identification and molecular data are available via PubChem.
Formulation Composition
Amount per mL:
-
Trimethylglycine (TMG): 30 mg
-
CDP-Choline (Citicoline): 45 mg
-
Arginine: 200 mg
-
N-Acetyl-L-Tyrosine (NALT): 35 mg
-
Norvaline: 35 mg
-
Lysine: 50 mg
-
Citrulline: 50 mg
Total Volume:
20 mL
Solvent System:
Sterile water with 1% benzyl alcohol
Physical and Chemical Properties
-
Appearance: Clear, colorless solution
-
Solubility: Fully dissolved aqueous formulation
-
Preservative: Benzyl alcohol 1%
-
Stability: Stable under cool, dry, and light-protected storage conditions
Research Focus Areas
MNT (PMP) is commonly examined in laboratory research related to:
-
Nitric oxide and vascular signaling pathways
-
Methylation and one-carbon metabolism
-
Amino acid synergy and metabolic efficiency
-
Choline-dependent membrane and signaling research
Research Use Disclaimer
MNT (PMP) is intended for research use only.
Not for human consumption, therapeutic use, or diagnostic application. All handling and use must comply with applicable laws, regulations, and laboratory safety standards.
Summary
MNT (PMP) is a compounded metabolic research solution combining CDP-choline, methyl donors, and nitric-oxide–related amino acids in an aqueous formulation. Its verified chemical identifiers for the primary component (CDP-choline) and clearly defined composition make it suitable for laboratory research focused on nitric oxide signaling, methylation balance, and amino acid-driven metabolic pathways.
No product specifications available.
